{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:40:05Z","timestamp":1756374005092,"version":"3.44.0"},"reference-count":35,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,5,14]]},"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>Blastic plasmacytoid dendritic cell neoplasm is a rare and aggressive haematopoietic neoplasm with poor prognosis. It usually presents with cutaneous lesions and symptoms secondary to bone marrow involvement. Due to rarity and lack of standard treatment protocols, these cases are difficult to diagnose and treat. We report a case of a female in early adolescence who presented with skin nodules on the leg. The diagnosis was established by immunophenotypic studies. We discuss the investigations and treatment options available to diagnose and treat this malignancy.<\/jats:p>","DOI":"10.1136\/bcr-2022-254008","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T11:20:21Z","timestamp":1685532021000},"page":"e254008","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Blastic plasmacytoid dendritic cell neoplasm in an adolescent female: a rare entity with challenging diagnosis and management"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3636-2447","authenticated-orcid":false,"given":"Ankit","family":"Agarwal","sequence":"first","affiliation":[{"name":"Pediatrics, Ascension Sacred Heart Hospital Pensacola, Pensacola, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Amit","sequence":"additional","affiliation":[{"name":"Pediatrics, Ascension Sacred Heart Hospital Pensacola, Pensacola, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Chaffin","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Florida, Gainesville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Strobel","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology, University of Florida, Pensacola, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"2025082802135066000_16.5.e254008.1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-Seq reveals new types of human blood Dendritic cells, monocytes, and Progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"2025082802135066000_16.5.e254008.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262"},{"key":"2025082802135066000_16.5.e254008.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"2025082802135066000_16.5.e254008.4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.leukres.2018.08.014","article-title":"Epidemiology and survival of Blastic Plasmacytoid Dendritic cell Neoplasm","volume":"73","author":"Guru Murthy","year":"2018","journal-title":"Leukemia Research"},{"key":"2025082802135066000_16.5.e254008.5","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2006.042135"},{"key":"2025082802135066000_16.5.e254008.6","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.238"},{"key":"2025082802135066000_16.5.e254008.7","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V87.4.1207.bloodjournal8741207","article-title":"Classification of natural killer (NK) cell and NK-like T-cell malignancies","volume":"87","author":"Jaffe","year":"1996","journal-title":"Blood"},{"key":"2025082802135066000_16.5.e254008.8","doi-asserted-by":"crossref","unstructured":"Alsomali DY , Bakshi N , Kharfan-Dabaja M , et al . Diagnosis and treatment of subcutaneous panniculitis-like T-cell lymphoma: A systematic literature review [published online ahead of print]. Hematology\/Oncology and Stem Cell Therapy May 2021. doi:10.1016\/j.hemonc.2021.04.001","DOI":"10.1016\/j.hemonc.2021.04.001"},{"key":"2025082802135066000_16.5.e254008.9","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/bloodadvances.2020001875","article-title":"Survival outcomes in Blastic Plasmacytoid Dendritic cell Neoplasm by first-line treatment and stem cell transplant","volume":"4","author":"Yun","year":"2020","journal-title":"Blood Adv"},{"key":"2025082802135066000_16.5.e254008.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.06.002"},{"key":"2025082802135066000_16.5.e254008.11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101345"},{"key":"2025082802135066000_16.5.e254008.12","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200207000-00003"},{"key":"2025082802135066000_16.5.e254008.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.4154"},{"key":"2025082802135066000_16.5.e254008.14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.072645"},{"key":"2025082802135066000_16.5.e254008.15","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.16"},{"key":"2025082802135066000_16.5.e254008.16","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12412"},{"key":"2025082802135066000_16.5.e254008.17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jdcr.2017.03.015","article-title":"Localized skin-limited Blastic Plasmacytoid Dendritic cell Neoplasm: A subset with possible durable remission without transplantation","volume":"3","author":"Amitay-Laish","year":"2017","journal-title":"JAAD Case Rep"},{"key":"2025082802135066000_16.5.e254008.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1556"},{"key":"2025082802135066000_16.5.e254008.19","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181c5e26b"},{"key":"2025082802135066000_16.5.e254008.20","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000156"},{"key":"2025082802135066000_16.5.e254008.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3297"},{"key":"2025082802135066000_16.5.e254008.22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-117531"},{"key":"2025082802135066000_16.5.e254008.23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-447599"},{"key":"2025082802135066000_16.5.e254008.24","doi-asserted-by":"publisher","DOI":"10.1309\/FY6PK436NBK0RYD4"},{"key":"2025082802135066000_16.5.e254008.25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-500413"},{"key":"2025082802135066000_16.5.e254008.26","doi-asserted-by":"publisher","DOI":"10.1309\/0QPPAVTUPCV9UCLV"},{"key":"2025082802135066000_16.5.e254008.27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404260"},{"key":"2025082802135066000_16.5.e254008.28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/107327481402100404","article-title":"Blastic Plasmacytoid Dendritic cell Neoplasm: update on molecular biology, diagnosis, and therapy","volume":"21","author":"Riaz","year":"2014","journal-title":"Cancer Control"},{"key":"2025082802135066000_16.5.e254008.29","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.18632\/oncotarget.4146","article-title":"Classification and clinical behavior of Blastic Plasmacytoid Dendritic cell Neoplasms according to their maturation-associated Immunophenotypic profile","volume":"6","author":"Mart\u00edn-Mart\u00edn","year":"2015","journal-title":"Oncotarget"},{"key":"2025082802135066000_16.5.e254008.30","doi-asserted-by":"crossref","first-page":"10174","DOI":"10.18632\/oncotarget.7101","article-title":"Blastic Plasmacytoid Dendritic cell Neoplasm frequently shows Occult central nervous system involvement at diagnosis and benefits from intrathecal therapy","volume":"7","author":"Mart\u00edn-Mart\u00edn","year":"2016","journal-title":"Oncotarget"},{"key":"2025082802135066000_16.5.e254008.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09373.x"},{"key":"2025082802135066000_16.5.e254008.32","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.026179"},{"key":"2025082802135066000_16.5.e254008.33","doi-asserted-by":"crossref","unstructured":"Sun W , Liu H , Kim Y , et al . First pediatric experience of SL-401, a Cd123-targeted therapy, in patients with Blastic Plasmacytoid Dendritic cell Neoplasm: report of three cases. J Hematol Oncol 2018;11. doi:10.1186\/s13045-018-0604-6","DOI":"10.1186\/s13045-018-0604-6"},{"key":"2025082802135066000_16.5.e254008.34","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0999"},{"key":"2025082802135066000_16.5.e254008.35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa1815105","article-title":"More on Blastic Plasmacytoid Dendritic-cell Neoplasms","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N Engl J Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-254008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:14:00Z","timestamp":1756372440000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-254008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,31]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1136\/bcr-2022-254008"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-254008","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}